Regulatory Action to Protect Access to Hydroxychloroquine for Approved Rheumatic Indications During COVID‐19 in New Zealand - KIVIRID

Regulatory Action to Protect Access to Hydroxychloroquine for Approved Rheumatic Indications During COVID‐19 in New Zealand

Authors: Eamon Duffy, Nicola Arroll, Richard Beasley, Thomas Hills

Published: 2021-01-10

DOI: 10.1002/art.41643

Source: Full article

Abstract

No abstract found.